MYCN and neuroblastoma: Indeed, N-Myc-addicted neuroblastoma cells are sensitive to a specific sub-class of ATP-competitive Aurora-A kinase inhibitors able to induce a conformational change of the kinase, resulting in disruption of the Aurora-A/N-Myc complex [55–57].